# Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)

> **NCT05237245** · — · ACTIVE_NOT_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 69 (estimated)

## Conditions studied

- Lymphoproliferation Induced by HTLV-1
- HTLV-1 Adult T-cell Lymphoma / Leukemia
- HTLV-1 Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05237245
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-23
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 69 (ESTIMATED)
- **Last updated:** 2026-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05237245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05237245, "Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05237245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*